
2012 Drug Trials Edge Towards an Alzheimer’s Cure
BioWorld’s top 10 stories for 2012 included the puzzling outcome of some massive Alzheimer’s trials. Find out how we are more-sure-than-ever of what ought to

BioWorld’s top 10 stories for 2012 included the puzzling outcome of some massive Alzheimer’s trials. Find out how we are more-sure-than-ever of what ought to

Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out

See a robot with a biological brain made of cultured neurons. Find out why this may hold a key to treating dementia, stroke & brain injury.

VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.

VIDEO + ARTICLE Researchers at Johns Hopkins Medicine surgically implanted a pacemaker-like device into the brain of a patient in the early stages of Alzheimer’s

VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down

Learn how Medicare has just added payment for more dementia therapy. Previously, therapy had to improve a condition. Now, maintaining it or even preventing & slowing deterioration are covered.

VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’

Alzheimer’s & Dementia Weekly is providing its regular stream of news services without interruption. Catch all the latest updates here, on Facebook or on Twitter.

MAUDE’S AWARDS: RECOGNIZING INNOVATIONS IN DEMENTIA CARE

A new Harvard study of 2,000 former NFL players shows one-third believe they have chronic traumatic encephalopathy (CTE), a neuropathological condition linked to repeated head trauma.

Teepa shows how to make the most from the ability to communicate with dementia. Watch now.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.

Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.
No spam, only news and updates.


